Abstract
Left ventricular assist device (LVAD) is a strong #therapeutic tool to
improve survival in patients with advanced heart failure, whereas not a
few patients have potentially abnormal #hemodynamics despite LVAD
supports. #Hemodynamic ramp test, which is recently proposed to undergo
following LVAD implantation, is a promising procedure to predict patient
clinical outcome by assessing hemodynamic profile and to improve
patients’ prognosis by optimizing hemodynamics via LVAD speed
adjustment. Further prospective randomized control trial is warranted to
clearly demonstrate clinical implication of the ramp test. Owing to the improvement of device technology, more
sophisticated management protocol, and #cumulating clinical
knowledge, actual survival for the patients with advanced heart
failure (HF) receiving left #ventricular assist device (LVAD)
improved dramatically during the recent several decades (Figure
1) [1]. Nevertheless, the rates of re-admission due to device-related
#comorbidities remain high and unsolved issues thus far [2].
For more articles on BJSTR Journal please click on https://biomedres.us/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.